Treatment of Central Nervous System Infection Caused by Multidrug-Resistant Klebsiella pneumoniae with Colistin Sulfate Intravenously and Intrathecally: A Case Report

Background: Due to the blood–brain barrier and limited antibiotic choices, polymyxin is currently the first-line agent for the treatment of central nervous system infections (CNSIs) caused by multidrug-resistant Gram-negative bacteria (MDR-GNB). Colistin sulfate, as a polymyxin E different from CMS,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xin, Zhong, Cejun, Chen, Haifeng, Xie, Xiaoqi, Lv, Xiaoju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787966/
https://www.ncbi.nlm.nih.gov/pubmed/36558933
http://dx.doi.org/10.3390/ph15121482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787966/
https://www.ncbi.nlm.nih.gov/pubmed/36558933
http://dx.doi.org/10.3390/ph15121482

Ejemplares similares